BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8052977)

  • 1. Associations of von Willebrand factor with age, sex and other risk factors for atherosclerosis.
    Blann AD
    Thromb Haemost; 1994 Apr; 71(4):528-9. PubMed ID: 8052977
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
    Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
    Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability of von Willebrand factor and atherosclerosis.
    Leebeek FW; van der Meer IM; Witteman JC
    Circulation; 2004 Aug; 110(5):e57. PubMed ID: 15289398
    [No Abstract]   [Full Text] [Related]  

  • 4. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
    Blann AD; Dobrotova M; Kubisz P; McCollum CN
    Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of socioeconomic levels and life style to fibrinogen and von Willebrand factor in healthy Venezuelans and those with ischemic cardiopathy].
    Rodríguez-Larralde A; Mijares ME; Nagy E; Espinosa R; Ryder E; Diez-Ewald MP; Torres E; Coll-Sangrona E; Rodríguez-Roa E; Carvajal Z; Lundberg U; Campos G; Gill A; Arocha-Piñango CL;
    Invest Clin; 2005 Jun; 46(2):157-68. PubMed ID: 16001747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities.
    Duncan BB; Schmidt MI; Chambless LE; Folsom AR; Carpenter M; Heiss G
    Obes Res; 2000 Jul; 8(4):279-86. PubMed ID: 10933303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
    Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
    Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
    Jastrzebska M; Torbus-Lisiecka B; Honczarenko K; Foltynska A; Chełstowski K; Naruszewicz M
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):132-40. PubMed ID: 12325470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand disease: laboratory aspects of diagnosis and treatment.
    Favaloro EJ; Lillicrap D; Lazzari MA; Cattaneo M; Mazurier C; Woods A; Meschengieser S; Blanco A; Kempfer AC; Hubbard A; Chang A
    Haemophilia; 2004 Oct; 10 Suppl 4():164-8. PubMed ID: 15479392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of stress electrocardiogram on platelet function, concentration of von Willebrand factor and fibrinogen in hypertensive patients and healthy subjects].
    Torres-Guerra E; Diez-Ewald M; Vizcaíno G; Arteaga-Vizcaíno M; Sulbarán T
    Invest Clin; 2000 Jun; 41(2):105-16. PubMed ID: 10961046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The risk factors in atherosclerosis].
    Marinescu M; Chiriae S; Mirea M; Cioroiu C
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1989 Sep; 37(9):193-8. PubMed ID: 2518501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor and endothelial damage in essential hypertension.
    Blann AD; Naqvi T; Waite M; McCollum CN
    J Hum Hypertens; 1993 Apr; 7(2):107-11. PubMed ID: 8510081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor: demographics of plasma protein level in a large blood donor cohort from South Wales in the United Kingdom.
    Davies JA; Hathaway LS; Collins PW; Bowen DJ
    Haemophilia; 2012 May; 18(3):e79-81. PubMed ID: 22458869
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis].
    Nomura E; Kohriyama T; Yamaguchi S; Kajikawa H; Nakamura S
    Rinsho Shinkeigaku; 1996 Jun; 36(6):741-5. PubMed ID: 8937194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
    Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
    Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.
    Kalyoncu U; Dizdar O; Erkan Duman A; Karadag O; Tufan A; Yucel O; Tayfur O; Sen D; Ulger Z; Kepez A; Kocabas U; Haznedaroglu I
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):103-8. PubMed ID: 18160605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.